{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:41:49Z","timestamp":1648935709450},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00508-009-1264-x","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T12:15:28Z","timestamp":1260274528000},"page":"690-699","source":"Crossref","is-referenced-by-count":2,"title":["Die Rationale f\u00fcr Knochenmarkuntersuchungen bei Patienten mit entz\u00fcndlich-rheumatischen Erkrankungen"],"prefix":"10.1007","volume":"121","author":[{"given":"Jutta G.","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Go\u00dfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00f6rte","family":"Huscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1264_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00124743-200102000-00011","volume":"7","author":"M Ehrenfeld","year":"2001","unstructured":"Ehrenfeld M, Shoenfeld Y (2001) Malignancies and autoimmune rheumatic diseases. J Clin Rheumatol 7: 47\u201350","journal-title":"J Clin Rheumatol"},{"key":"1264_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald, et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98: 51\u201360","journal-title":"J Natl Cancer Inst"},{"key":"1264_CR3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","volume":"66","author":"B L\u00f6fstr\u00f6m","year":"2007","unstructured":"L\u00f6fstr\u00f6m B, Backlin C, Sundstr\u00f6m C, Ekbom A, Lundberg IE (2007) A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 66: 1627\u20131632","journal-title":"Ann Rheum Dis"},{"key":"1264_CR4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sj\u00f6gren's Syndrome. Arthritis Rheum 42: 1765\u20131772","journal-title":"Arthritis Rheum"},{"key":"1264_CR5","first-page":"100","volume":"35","author":"M Faurschou","year":"2008","unstructured":"Faurschou M, Sorensen IJ, Mellemkjaer L, Loft AG, Thomsen BS, Tvede N, Baslund B (2008) Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35: 100\u2013105","journal-title":"J Rheumatol"},{"key":"1264_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.bor.0000209423.39033.94","volume":"18","author":"S Bernatsky","year":"2006","unstructured":"Bernatsky S, Ramsey-Goldman R, Clarke A (2006) Malignancy and autoimmunity. Curr Opin Rheumatol 18: 129\u2013134","journal-title":"Curr Opin Rheumatol"},{"key":"1264_CR7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","volume":"48","author":"E Baecklund","year":"2003","unstructured":"Baecklund E, Sundstr\u00f6m C, Ekbom A, Catrina AI, Biberfeld P, Feltelius N, et al (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48: 1543\u20131550","journal-title":"Arthritis Rheum"},{"key":"1264_CR8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ajh.20593","volume":"81","author":"M Voulgarelis","year":"2006","unstructured":"Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG (2006) Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol 81: 590\u2013597","journal-title":"Am J Hematol"},{"key":"1264_CR9","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch intern Med 165: 2337\u20132344","journal-title":"Arch intern Med"},{"key":"1264_CR10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","volume":"98","author":"O Landgren","year":"2006","unstructured":"Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 98: 1321\u20131330","journal-title":"J Natl Cancer Inst"},{"key":"1264_CR11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2362.2004.01417.x","volume":"34","author":"M Voulgarelis","year":"2004","unstructured":"Voulgarelis M, Giannouli S, Ritis K, Tzioufas AG (2004) Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 34: 690\u2013700","journal-title":"Eur J Clin Invest"},{"key":"1264_CR12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.revmed.2005.06.012","volume":"26","author":"F Bouali","year":"2007","unstructured":"Bouali F, Berrah A, Si Ahmed-Bouali, Harrieche F, Benhalima M, Hamladji RM, et al (2007) Immological abnormalities in myelodysplastic syndroms. Prospective study (series of 40 patients). Rev Med Interne 26: 777\u2013783","journal-title":"Rev Med Interne"},{"key":"1264_CR13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000083454","volume":"113","author":"AA Giagounidis","year":"2005","unstructured":"Giagounidis AA, Haase S, Germing U, Heinsch M, Aul C, (2005) Autoimmune disorders in two patients with myelodysplastic syndrome and 5q deletion. Acta Haematol 113: 146\u2013149","journal-title":"Acta Haematol"},{"key":"1264_CR14","first-page":"311","volume":"23","author":"S Zhao","year":"2002","unstructured":"Zhao S, Mao H, Wang H, Yu J (2002) The relationship between myelodysplastic syndromes and autoimmune disorders. Zhonghua Xue Ye Xue Za Zhi 23: 311\u2013313","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1264_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","volume":"22","author":"L V\u00e1r\u00f3czy","year":"2002","unstructured":"V\u00e1r\u00f3czy L, Gergely L, Zeher M, Szegedi G, Ill\u00e9s A (2002) Malignant lymphoma-associated autoimmune diseases \u2013 a descriptive epidemiological study. Rheumatol Int 22: 233\u2013237","journal-title":"Rheumatol Int"},{"key":"1264_CR16","first-page":"485","volume":"11","author":"A Chloraki-Bobota","year":"2006","unstructured":"Chloraki-Bobota A, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, et al (2006) Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases. J BUON 11: 485\u2013489","journal-title":"J BUON"},{"key":"1264_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","volume":"67","author":"S Bernatsky","year":"2008","unstructured":"Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, et al (2008) The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis 67: 74\u201379","journal-title":"Ann Rheum Dis"},{"key":"1264_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/1042819021000030045","volume":"44","author":"HA Papadaki","year":"2003","unstructured":"Papadaki HA, Xylouri I, Katrinakis G, Foudoulakis A, Kritikos HD, Stathopoulos EN, et al (2003) Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus. Leuk Lymphoma 44: 275\u2013279","journal-title":"Leuk Lymphoma"},{"key":"1264_CR19","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","volume":"42","author":"KC S\u00f6derberg","year":"2006","unstructured":"S\u00f6derberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M (2006) Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer 42: 3028\u20133033","journal-title":"Eur J Cancer"},{"issue":"2","key":"1264_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.rdc.2005.01.002","volume":"31","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Ramsey-Goldman R, Clarke A (2005) Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am 31 (2): 387\u2013402, VIII\u2013IX","journal-title":"Rheum Dis Clin North Am"},{"key":"1264_CR21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","volume":"10","author":"J Cibere","year":"2001","unstructured":"Cibere J, Sibley J, Haga M (2001) Systemic lupus erythematosus and the risk of malignancy. Lupus 10: 394\u2013400","journal-title":"Lupus"},{"key":"1264_CR22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","volume":"50","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50: 1740\u20131751","journal-title":"Arthritis Rheum"},{"key":"1264_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard.60.3.199","volume":"60","author":"A Zink","year":"2001","unstructured":"Zink A, Listing J, Klindworth C, Zeidler H for the German Collaborative Arthritis Centres (2001) The national database of the german collaborative arthritis centres \u2013 structure, aims, and patients. Ann Rheum Dis 60: 199\u2013206","journal-title":"Ann Rheum Dis"},{"key":"1264_CR24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/1529-0131(199808)41:8<1493::AID-ART21>3.0.CO;2-5","volume":"41","author":"CJ McCarthy","year":"1998","unstructured":"McCarthy CJ, Sheldon S, Ross CW, McCune WJ (1998) Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease. Arthritis Rheum 41: 1493\u20131496","journal-title":"Arthritis Rheum"},{"key":"1264_CR25","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414\u20131420","journal-title":"Ann Rheum Dis"},{"key":"1264_CR26","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/art.22277","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, et al (2006) Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum 54: 3774\u20133781","journal-title":"Arthritis Rheum"},{"key":"1264_CR27","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/kel444","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Ramsey-Goldman R, Isenberg D, Rahman A, Dooley MA, Sibley J, et al (2007) Hodgkin's lymphoma in systemic lupus erythematosus. Rheumatology (Oxford) 46: 830\u2013832","journal-title":"Rheumatology (Oxford)"},{"key":"1264_CR28","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","volume":"52","author":"S Bernatsky","year":"2005","unstructured":"Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, et al (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52: 1481\u20131490","journal-title":"Arthritis Rheum"},{"key":"1264_CR29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","volume":"3","author":"A Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 3: 561\u2013569","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1264_CR30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.1992.tb06430.x","volume":"82","author":"C Aul","year":"1992","unstructured":"Aul C, Gattermann N, Schneider W (1992) Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 82: 358\u2013367","journal-title":"Br J Haematol"},{"key":"1264_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00393-006-0105-9","volume":"65","author":"P Whelan","year":"2006","unstructured":"Whelan P (2006) Link between rheumatoid arthritis and cancer. Z Rheumatol 65: 497\u2013498, 500\u2013502, 504","journal-title":"Z Rheumatol"},{"key":"1264_CR32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","volume":"26","author":"JK King","year":"2007","unstructured":"King JK, Costenbader KH (2007) Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). Clin Rheumatol 26: 1491\u20131494","journal-title":"Clin Rheumatol"},{"key":"1264_CR33","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ajh.21003","volume":"82","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujimaki K, Shirasugi Y, Yoshiba F, Ohsaka M, Miyazaki K, et al (2007) Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol 82: 1106\u20131109","journal-title":"Am J Hematol"},{"key":"1264_CR34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","volume":"22","author":"E Toussirot","year":"2008","unstructured":"Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 22: 883\u2013896","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1264_CR35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","volume":"15","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Baecklund E, Askling J (2006) Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 15: 2069\u20132077","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1264_CR36","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al (2006) Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692\u2013701","journal-title":"Arthritis Rheum"},{"key":"1264_CR37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ijc.11311","volume":"106","author":"JR Cerhan","year":"2003","unstructured":"Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM (2003) Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 106: 784\u2013788","journal-title":"Int J Cancer"},{"key":"1264_CR38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/rheumatology\/kel396","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Lee JL, Rahme E (2007) Non-Hodgkin's lymphoma \u2013 meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories. Rheumatology (Oxford) 46: 690\u2013694","journal-title":"Rheumatology (Oxford)"},{"key":"1264_CR39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/aje\/kwi311","volume":"162","author":"ET Chang","year":"2005","unstructured":"Chang ET, Smedby KE, Hjalgrim H, Sch\u00f6llkopf C, Porwit-MacDonald A, Sundstr\u00f6m C, et al (2005) Medication use and risk of non-Hodgkin's lymphoma. Am J Epidemiol 162: 965\u2013974","journal-title":"Am J Epidemiol"},{"key":"1264_CR40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1021953224822","volume":"13","author":"I Kato","year":"2002","unstructured":"Kato I, Koenig KL, Shore RE, Baptiste MS, Lillquist PP, Frizzera G, et al (2002) Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control 13: 965\u201374","journal-title":"Cancer Causes Control"},{"key":"1264_CR41","first-page":"5510s","volume":"52","author":"L Bernstein","year":"1992","unstructured":"Bernstein L, Ross RK (1992) Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res. 52: 5510s\u20135515s","journal-title":"Cancer Res"},{"key":"1264_CR42","doi-asserted-by":"crossref","unstructured":"Hellgren K, Iliadou A, Rosenquist R, Feltelius N, Backlin C, Enblad G, et al (2009) Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas \u2013 results from a case-control study. Ann Rheum Dis 2009 May (Epub ahead of print)","DOI":"10.1136\/ard.2008.096925"},{"key":"1264_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00277-006-0249-3","volume":"86","author":"AA Muslimani","year":"2007","unstructured":"Muslimani AA, Spiro TP, Chaudhry AA, Daw HA (2007) Secondary myelodysplastic syndrome after hydroxychloroquine therapy. Ann Hematol 86: 531\u2013534","journal-title":"Ann Hematol"},{"key":"1264_CR44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.23716","volume":"59","author":"R Buchbinder","year":"2008","unstructured":"Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, et al D (2008) Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 59: 794\u2013799","journal-title":"Arthritis Rheum"},{"key":"1264_CR45","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","volume":"99","author":"X Mariette","year":"2002","unstructured":"Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909\u20133915","journal-title":"Blood"},{"key":"1264_CR46","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","volume":"14","author":"E Salloum","year":"1996","unstructured":"Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943\u20131949","journal-title":"J Clin Oncol"},{"key":"1264_CR47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","volume":"328","author":"OW Kamel","year":"1993","unstructured":"Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, et al (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328: 1317\u20131321","journal-title":"N Engl J Med"},{"key":"1264_CR48","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/1529-0131(199811)41:11<1930::AID-ART6>3.0.CO;2-N","volume":"41","author":"BE van den Borne","year":"1998","unstructured":"van den Borne BE, Landew\u00e9 RB, Houkes I, Schild F, van der Heyden PC, Hazes JM , et al (1998) No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum 41: 1930\u20131937","journal-title":"Arthritis Rheum"},{"key":"1264_CR49","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/rheumatology\/35.8.738","volume":"35","author":"M Jones","year":"1996","unstructured":"Jones M, Symmons D, Finn J, Wolfe F (1996) Does exposure to immunosuppressive therapy does increase the 10 year malignancy and mortality risks in rhoimatoid arthritis? A matched cohort study. Br J Rheumatol 35: 738\u2013745","journal-title":"Br J Rheumatol"},{"key":"1264_CR50","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.47.12.988","volume":"47","author":"AJ Silman","year":"1988","unstructured":"Silman AJ, Petrie J, Hazleman B, Evans SJ (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 47: 988\u2013992","journal-title":"Ann Rheum Dis"},{"key":"1264_CR51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2008-1027578","volume":"33","author":"G Riemekasten","year":"2008","unstructured":"Riemekasten G und die Kommission Pharmakotherapie der Deutschen Gesellschaft f\u00fcr Rheumatologie (2008) Toxizit\u00e4t von Azathioprin Azathioprine \u2013 Its Toxicity and Side Effects. Akt Rheumatol 33: 211\u2013216","journal-title":"Akt Rheumatol"},{"key":"1264_CR52","first-page":"691","volume":"90","author":"S Knipp","year":"2005","unstructured":"Knipp S, Hildebrandt B, Richter J, Haas R, Germing U, Gattermann N (2005) Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7. Haematologica 90: 691\u2013693","journal-title":"Haematologica"},{"key":"1264_CR53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1191\/135248506ms1307cr","volume":"12","author":"N Putzki","year":"2006","unstructured":"Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener HC, et al (2006) Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis. Mult Scler 12: 363\u2013366","journal-title":"Mult Scler"},{"key":"1264_CR54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00508-008-1058-6","volume":"120","author":"R Stauder","year":"2008","unstructured":"Stauder R, Wimazal F, N\u00f6sslinger T, Krieger O, Sperr WR, Sill H, et al (2008) Individualized management and therapy of myelodysplastic syndromes. Wien Klin Wochenschr 120: 523\u2013537","journal-title":"Wien Klin Wochenschr"},{"key":"1264_CR55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"85","author":"G Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307\u2013311","journal-title":"J Natl Cancer Inst"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1264-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-009-1264-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-009-1264-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:53:19Z","timestamp":1559080399000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-009-1264-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":55,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s00508-009-1264-x","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}